Alopecia Areata: Current and Emerging Therapies

    January 2024 in “ Physiotherapia Croatica ”
    Hanna Theresa Sterk
    From the encyclopedia
    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Baricitinib →

    JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases

    Studysummary This review discusses the complex pathogenesis and clinical presentation of Alopecia Areata, highlighting emerging therapies that may offer hope for severe cases but reports no new results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Alopecia Areata (AA) is an autoimmune disorder causing non-scarring hair loss, with unclear pathogenesis involving genetic, immune, and environmental factors. It affects all ages, peaking in the second and third decades, and can progress from patchy hair loss to total scalp or body hair loss. Diagnosis is primarily clinical, with treatment varying by severity. Mild cases may use topical therapies, while severe cases require systemic treatments like immunosuppressants. New treatments, such as JAK inhibitors like baricitinib and ritlecitinib, show promise for severe AA, offering hope for hair regrowth and improved quality of life.
    Discuss this study in the Community →